The proper choice of antibiotic for Clostridium perfringens infections in patients allergic to penicillin is not dear; the usual recommendations and recent in vitro studies disagree. We tested the susceptibility of 57 strains ofC. perfringens to eight penicillins, seven cephalosporins, two tetracyclines, clindamycin, chloramphenicol, and rifampin by the agar dilution method. All strains were inhibited by (per milliliter) 4 ,ug or less of any of the penicillins, chloramphenicol, or clindamycin and 8 ,mg or less of any of the cephalosporins tested. Penicillin G and amoxicillin inhibited all strains at 0.12 ,g or less per ml. Only 54% of the strains were inhibited by 1 ,ug of tetracycline per ml. Penicillin G remains the drug of first choice for infections with C. perfringens; it need not be added to a regimen containing a penicillinase-resistant penicillin given parenterally in high doses. The cephalosporins should be considered as alternative drugs for penicillin-allergic patients. Clindamycin and chloramphenicol are also effective. Tetracyclines cannot be depended upon in clostridial infections without in vitro testing, which is impracticable for initial empirical therapy.
Penicillin G is the antibiotic of first choice for treating cellulitis, sepsis, and myonecrosis caused by Clostridium perfringens (1, 2, 8, 11, 18) . Although erythromycin and tetracycline are the alternative drugs usually recommended (1, 2, 8, 11, 18), 10 to 30% of C. perfringens are resistant to tetracycline, and a few strains are also resistant to erythromycin (6, 8, 9, 13) . Cephalosporins and penicillinase-resistant and other semisynthetic penicillins are used for contaminated wounds after severe trauma and for suspected sepsis in patients with cancer, who are also at a higher risk for clostridial infections (3, 4, 14) . Because of both scanty information about many of these agents and the need for a safe antibiotic for penicillin-allergic patients, we studied the activity of 20 Susceptibility testing. Agar dilution tests were done by the method of Sutter and Washington (15) .
Antibiotics were diluted in twofold steps above and below 1 pg/ml in Brucella agar (Pfizer) supplemented with 5% laked sheep blood and vitamin K1 (10 ug/ml). The inoculum was adjusted to a no. 1 MacFarland turbidity standard (3 x 108 colonyforming units) and then diluted with prereduced Carey-Blair buffer, so that each spot delivered by the multipoint inoculator contained between 104 and 105 organisms. The viable counts were confirmed by the method of Miles and Misra (10) . Tests were done in triplicate, and a control strain of C. perfringens (CDC no. 15443) was included with each experiment. Growth was defined as more than one discrete colony on at least two out of three spots after incubation at 350C in an anaerobic glove box in an atmosphere of 85% N2, 5% C02, and 10% H2 for 24 and 48 h.
RESULTS
End points at 24 and 48 h were similar, except that 12% of the minimal inhibitory concentrations (MIC) at 48 h were one dilution step higher. The MIC of the control strain of C.
perfringens was always within one twofold-dilution step of the MIC reported by the CDC or our earlier results for antibiotics not tested by the CDC. The results shown in Table 1 are those obtained at 24 h. Penicillin G and amoxicillin had the lowest MIC. One hundred percent of the strains were inhibited by 0.12 ug of either antibiotic per ml. All the semisynthetic penicillins and cephalosporins tested were active against C. perfringens at concentrations readily achieved in human serum with usual doses. Chloramphenicol and clindamycin were also active over a narrow range against all strains. In contrast, 19% of strains were resistant to 4 ,ug oftetracycline per ml. Rifampin inhibited all but one strain at 0.015 ,ug/ml; the remaining strain was 500-fold more resistant. DISCUSSION Our results for penicillin G agree with those of others who used similar methods (6, 8, 9, 13 ). The semisynthetic penicillins tested were also active against C. perfringens. Any of the penicillins we tested should constitute effective therapy against C. perfringens. Our findings with cephalosporins agree with published results for cefamandole, cephalexin, cephaloridine, and cephalothin (16, 17) . Cefazolin, cefoxitin, and cephradine showed activity comparable to the other cephalosporins. Our results with chloramphenicol and clindamycin were similar to those of others (6, 8, 9, 13) . We also found resistance to tetracyclines among strains of C. perfringens (6, 8, 9, 13) . About half of our strains were inhibited by 1 ,g of tetracycline per ml, but 64 ,ug/ml was required to inhibit 100% of strains; 21% of strains required more than 1 ,ug of doxycycline per ml.
Tetracyclines may be chemically inactivated in environments having low oxidation-reduction potentials (7) . Erythromycin is much less active, if at all, at a low redox potential and an acid pH (12) . The acidosis and anaerobic environment in myonecrosis caused by C. perfringens (19) would contraindicate the use of these drugs on theoretical grounds. Penicillin, ampicillin, and cephalothin are not appreciably affected by different pH conditions in media (13) .
In conclusion, our data support the efficacy of all the penicillins tested against C. perfringens. Neither tetracycline nor erythromycin should be considered as an alternative drug for infection with C. perfringens, unless susceptibility can be demonstrated by appropriate testing. In most penicillin-allergic patients, a cephalosporin would be both safe and effective treatment for C. perfringens (5, 18) ; clindamycin and chloramphenicol would be alternative drugs.
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